Usa state Virginia covid-19 Government medicines patient Usa state Virginia

Phlow secures $354m US contract for drug supply amid Covid-19

Reading now: 565
www.pharmaceutical-technology.com

US-based public benefit drug manufacturing corporation Phlow has received $354m funding from the government to produce essential medicines at risk of shortage amid the Covid-19 pandemic.

The contract from the Biomedical Advanced Research and Development Authority (BARDA) also covers advanced manufacturing of drugs for potential Covid-19 treatment.

Valued up to $812m, the contract involves a four-year base award of $354m and additional $458m as potential options for long-term sustainability.

Phlow is working with its partners Civica Rx, Virginia Commonwealth University’s Medicines for All Institute and AMPAC Fine Chemicals to produce chemical precursor ingredients and active pharmaceutical ingredients (APIs).

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA